TR200102700T2 - Treatment of abdominal hernia (hiatal hernia). - Google Patents

Treatment of abdominal hernia (hiatal hernia).

Info

Publication number
TR200102700T2
TR200102700T2 TR2001/02700T TR200102700T TR200102700T2 TR 200102700 T2 TR200102700 T2 TR 200102700T2 TR 2001/02700 T TR2001/02700 T TR 2001/02700T TR 200102700 T TR200102700 T TR 200102700T TR 200102700 T2 TR200102700 T2 TR 200102700T2
Authority
TR
Turkey
Prior art keywords
hernia
treatment
hiatal
abdominal
hiatal hernia
Prior art date
Application number
TR2001/02700T
Other languages
Turkish (tr)
Inventor
M. Mendel Carl
B. Seaton Timothy
P. Weinstein Steve
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of TR200102700T2 publication Critical patent/TR200102700T2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

R1 VE R2'nin biribirleridnden bagimsiz olarak H veya metil oldugu formül I'in bir bilesimi veya bunlarin farmasötik olarak kabulkabul edilen tuzlari (örnegin, seçime bagli olarak monihdrati yapisinda N,N-dimetil-1-[1-(4-klorofenil) sislobütil]-3-metilbtil amin hidroklorit) hiatal hernia ve reflux oesephagitis in tedavisi için kullailirlar.A combination of formula I wherein R1 and R2 are independently H or methyl from each other, or their pharmaceutically acceptable salts (for example, N, N-dimethyl-1- [1- (4-chlorophenyl) cyslobutyl optionally in the monihdrati structure) ] -3-methylbethyl amine hydrochloride) are used for the treatment of hiatal hernia and reflux oesephagitis.

TR2001/02700T 1999-03-19 2000-03-17 Treatment of abdominal hernia (hiatal hernia). TR200102700T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12511699P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
TR200102700T2 true TR200102700T2 (en) 2002-04-22

Family

ID=22418261

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02700T TR200102700T2 (en) 1999-03-19 2000-03-17 Treatment of abdominal hernia (hiatal hernia).

Country Status (20)

Country Link
EP (1) EP1169028A1 (en)
JP (1) JP2002539249A (en)
KR (1) KR20030006909A (en)
CN (1) CN1376061A (en)
AU (1) AU3894400A (en)
BG (1) BG106000A (en)
BR (1) BR0009160A (en)
CA (1) CA2367035A1 (en)
CZ (1) CZ20013279A3 (en)
HK (1) HK1044703A1 (en)
HU (1) HUP0200498A2 (en)
IL (1) IL145242A0 (en)
MX (1) MXPA01009463A (en)
NO (1) NO20014476L (en)
NZ (1) NZ514013A (en)
PL (1) PL351081A1 (en)
SK (1) SK13392001A3 (en)
TR (1) TR200102700T2 (en)
WO (1) WO2000056307A1 (en)
ZA (1) ZA200107679B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006833B (en) * 2012-12-31 2014-02-12 代凤玲 Medicine for hiatus hernia postoperative rehabilitation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver

Also Published As

Publication number Publication date
ZA200107679B (en) 2003-06-18
PL351081A1 (en) 2003-03-10
CN1376061A (en) 2002-10-23
HK1044703A1 (en) 2002-11-01
IL145242A0 (en) 2002-06-30
CZ20013279A3 (en) 2002-07-17
AU3894400A (en) 2000-10-09
HUP0200498A2 (en) 2002-08-28
NZ514013A (en) 2001-09-28
KR20030006909A (en) 2003-01-23
WO2000056307A1 (en) 2000-09-28
NO20014476D0 (en) 2001-09-14
MXPA01009463A (en) 2004-03-19
BR0009160A (en) 2002-01-29
SK13392001A3 (en) 2002-04-04
CA2367035A1 (en) 2000-09-28
JP2002539249A (en) 2002-11-19
NO20014476L (en) 2001-10-29
EP1169028A1 (en) 2002-01-09
BG106000A (en) 2002-06-28

Similar Documents

Publication Publication Date Title
NO20021328L (en) Pyrazolopyrimidia as therapeutic agents
DK1392666T3 (en) Biologically active methylene blue derivatives
TR200102646T2 (en) Treating eating disorders.
ATE495187T1 (en) DALDA ANALOGUES AND THEIR USE
ATE416157T1 (en) INHIBITORS OF INTEGRIN ALPHA-V-BETA-6
SE0004245D0 (en) Novel compounds and their use
NO20012194D0 (en) CRF receptor antagonists and associated methods
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
NO20012228D0 (en) CRF receptor antagonists and associated methods
NO20022200L (en) Compound with growth hormone releasing properties
DK1379508T3 (en) N- (aryl) -2arylethenesulfonamides and therapeutic uses thereof
WO2000056315A8 (en) Treatment of pain
DK1483243T3 (en) Preparation of N1- (2'-pyridyl) -1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
TR200101654T2 (en) Vitronectin receptor antagonists
TR200102700T2 (en) Treatment of abdominal hernia (hiatal hernia).
TR200102699T2 (en) Treatment of chronic joint disorder (osteoarthritis)
ATE250058T1 (en) CRF RECEPTOR ANTAGONISTS AND RELATED METHODS
MXPA01009469A (en) Treatment to lower platelet adhesiveness.
MXPA01009468A (en) Treatment of pulmonary hypertension.
ATE260918T1 (en) CRF RECEPTOR ANTAGONISTS AND RELATED METHODS
SE9901901D0 (en) Compounds
ECSP034549A (en) CRYSTALLINE FORMS OF 1- (6-CHLORINE-5- (TRIFLUOROMETIL) -2-PIRIDINIL) HYDROCHLORIDE PIPERAZINE
SE9603284D0 (en) New compounds
TR200102694T2 (en) Weight loss after pregnancy.
ATE374192T1 (en) 1-(2-M-METHANESULFONAMIDOPHENYLETHYL)-4-(M-TRIFLUOROMETHYLPHENYL)PIPERAZINE AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND SOLVATES AND THEIR USE FOR THE TREATMENT OF INCONTINENCE